Administrative Practices and Procedures; Formal Hearings

Forms and Documents

Document Name	Status
0191_Consolidation of 0566.docx Justification for No Material/Nonsubstantive Change	2023-09-06
0191 Admin Regs SSA 2023 REV.docx Supporting Statement A	2023-06-30

IC Document Collections

IC ID	Document Title	Status
5800	Notice of participation	Unchanged
262057	Dispute Resolution Procedures for Science Based Decisions on Products Regulated by the CVM Other-Agency Guidance	New
260314	Requests for FDA speakers at external events Other-Screenshot of Web Forms	Unchanged
242055	Meetings and correspondence	Unchanged
242054	Guidance submissions for proposed development and/or withdraw	Unchanged
242053	Request for waiver, suspection, or modification of requirements	Unchanged
216312	Filing Objections and Requests for a Hearing on a Regulation or Order	Unchanged
216311	Advisory Opinions	Unchanged
216309	Administrative Stay of Action	Unchanged
216308	Administrative Reconsideration of Action	Unchanged
216306	Citizen petitions and petitions related to ANDA, certain NDAs, and certain BLAs Other-Agency Guidance Document	Unchanged

ICR Details

OMB Control No: 0910-0191	ICR Reference No: 202309-0910-006
Status: Received in OIRA	Previous ICR Reference No: 202305-0910-007
Agency/Subagency: HHS/FDA	Agency Tracking No: OC
Title: Administrative Practices and Procedures; Formal Hearings
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 09/06/2023

	Requested	Previously Approved
Expiration Date	08/31/2026	08/31/2026
Responses	4,219	4,215
Time Burden (Hours)	6,400	6,360
Cost Burden (Dollars)	0	0

---

Abstract: This information collection supports Food and Drug Administration (FDA, the agency, us or we) regulations found in 21 CFR Part 10, 21 CFR Parts 12 through 16, and 21 CFR Part 19 (21 CFR §§ 10, 12-16, and 19). These regulations are established in accordance with the Administrative Procedures Act and implement administrative practice and procedures to give instructions to those conducting business with FDA.

---

Authorizing Statute(s): US Code: 21 USC 371 Name of Law: FFDCA
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	88 FR 7981	02/07/2023
30-day Notice:	Federal Register Citation:	Citation Date:
	88 FR 38057	06/12/2023
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 11

IC Title	Form No.	Form Name
Administrative Reconsideration of Action
Administrative Stay of Action
Advisory Opinions
Citizen petitions and petitions related to ANDA, certain NDAs, and certain BLAs
Dispute Resolution Procedures for Science Based Decisions on Products Regulated by the CVM
Filing Objections and Requests for a Hearing on a Regulation or Order
Guidance submissions for proposed development and/or withdraw
Meetings and correspondence
Notice of participation
Request for waiver, suspection, or modification of requirements
Requests for FDA speakers at external events

---

ICR Summary of Burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	4,219	4,215	0	0	4	0
Annual Time Burden (Hours)	6,400	6,360	0	0	40	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: For efficiency of agency operations, we are requesting to consolidate the related information collection activity and account for burden we attribute to the recommendations for dispute resolution affecting animal drugs or other products that are regulated by Center for Veterinary Medicine (CVM).

---

Annual Cost to Federal Government: $469,972

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 09/06/2023

---